Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Hum Pathol ; 37(1): 23-31, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16360412

RESUMO

We set out to analyze the presence of Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) in different neoplasms occurring in East Africa, a region characterized by a high KSHV/HHV-8 seroprevalence rate and endemic Kaposi's sarcoma (KS). Our results suggest that, in endemic regions of Africa, KSHV/HHV-8 is predominantly associated with KS, independently of HIV status. During the course of this study, other important information came to light. We found the presence of KSHV/HHV-8 in 2 cases of lymph nodes partially involved by Burkitt's lymphoma and KS and in 1 case of multicentric Castleman disease. Our immunophenotypic and molecular data seem to suggest 2 different mechanisms of viral infection are at work in lymphoid cells. On one hand, when B cells show a latent phase infection with KSHV/HHV-8, after the germinal center reaction, naive B cells become resting memory B cells, similarly to Epstein-Barr virus-infected B cells. On the other hand, when lytic genes such as vIL6 are expressed in naive B cells, they may be driven to differentiate into plasmablasts without undergoing germinal center reaction. Interestingly, among KSHV/HHV-8-positive cases, in those in which there was also lymphoma, the neoplastic cells were negative for KSHV/HHV-8. This further confirms that KSHV/HHV-8 is involved in the neoplastic transformation of only certain types of lymphoma, probably in relation to their precursor infected cell. In conclusion, the maturation stage of KSHV/HHV-8-positive B cells as well as the type of viral infection may well determine the morphological, phenotypic, and clinical characteristics of KSHV/HHV-8-associated lymphomas.


Assuntos
Centro Germinativo/virologia , Herpesvirus Humano 8/isolamento & purificação , Linfoma/virologia , Sarcoma de Kaposi/virologia , Adulto , Antígenos Virais , Linfócitos B/patologia , Linfócitos B/virologia , Linfoma de Burkitt/patologia , Linfoma de Burkitt/virologia , Hiperplasia do Linfonodo Gigante/patologia , Hiperplasia do Linfonodo Gigante/virologia , Transformação Celular Neoplásica , Criança , DNA Viral/análise , Feminino , Centro Germinativo/patologia , HIV/genética , HIV/isolamento & purificação , Herpesvirus Humano 4/genética , Herpesvirus Humano 4/isolamento & purificação , Herpesvirus Humano 8/genética , Herpesvirus Humano 8/imunologia , Humanos , Linfoma/patologia , Masculino , Pessoa de Meia-Idade , Proteínas Nucleares , RNA Viral/análise , Estudos Retrospectivos , Sarcoma de Kaposi/patologia
2.
Int J Oncol ; 23(6): 1529-35, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14612923

RESUMO

Aberrations of genes/proteins regulating cell cycle and growth, increased proliferation and telomerase activity (TA) are documentable in glioblastoma multiforme. TA is more frequently detectable in secondary glioblastoma, which is also characterized by p53 mutation/overexpression. Discordant telomere (Te) length values have been reported in glioblastomas with and without TA. In 31 glioblastomas, in which pre-existing astrocytoma was not documented, we compared cases with and without TA for the expression of p53, EGFR, c-Myc, MIB-1 and Topoisomerase IIalpha; p53 mutations were also investigated by SSCP-PCR. Correlations were made with Te parameters [TePs: number (TeNo), length and area] as evaluated by image analysis in interphase nuclei of fluorescence in situ hybridization (FISH)-processed sections. We found no differences in the expression of the proteins evaluated and in TePs, except Te/nuclear area %, which was significantly lower in TA+ cases (p=0.02). TePs were, instead, inversely correlated with TA (p=0.0001). TA was positively correlated with MIB1 staining index in the TA+ cases (p=0.033), which also showed a positive correlation between TeNo and EGFR expression (p=0.042), and a trend towards a negative correlation between TeNo and p53 expression (p=0.05). Tumors overexpressing EGFR had a significantly shorter lifetime (p=0.0001). TeNo seems to be inversely correlated to tumor proliferation and lifetime in glioblastoma multiforme.


Assuntos
Glioblastoma/enzimologia , Hibridização in Situ Fluorescente/métodos , Telomerase/metabolismo , Telômero/ultraestrutura , Fosfatase Ácida/metabolismo , Adolescente , Adulto , Antígenos de Neoplasias , Neoplasias Encefálicas/enzimologia , Divisão Celular , Criança , DNA Topoisomerases Tipo II/metabolismo , Proteínas de Ligação a DNA , Receptores ErbB/metabolismo , Glioblastoma/metabolismo , Glioblastoma/patologia , Humanos , Processamento de Imagem Assistida por Computador , Isoenzimas/metabolismo , Antígeno Ki-67/biossíntese , Antígeno Ki-67/metabolismo , Pessoa de Meia-Idade , Polimorfismo Conformacional de Fita Simples , Proteínas Proto-Oncogênicas c-myc/metabolismo , Fosfatase Ácida Resistente a Tartarato , Proteína Supressora de Tumor p53/metabolismo
3.
J Immunol ; 174(11): 7210-6, 2005 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-15905566

RESUMO

The correct interaction of a costimulatory molecule such as CD40L with its contrareceptor CD40 expressed on the membrane of professional APCs, provides transmembrane signaling that leads to APC activation. This process can be exploited to significantly improve the efficacy of cancer vaccines and the outcome of a possible cancer vaccine-induced, Ag-specific CTL response. Therefore, we investigated whether a novel intranasal delivery of immune-reconstituted influenza virosomes (IRIV), assembled with the CD40L gene (CD40L/IRIV), could be used to improve protective immunity and the Ag-specific CTL response against carcinoembryonic Ag (CEA) generated with a novel vaccine constituted of IRIV assembled with the CEA gene (CEA/IRIV). Our results suggest that CD40L/IRIV was able to augment CEA-specific CTL activity and CEA-specific protective immunity induced by CEA/IRIV most likely through the induction of a CTL response associated with a Th1 phenotype. In conclusion, we provide evidence that CD40L/IRIV, by acting through the CD40L/CD40 signaling pathway, acts as an immune-adjuvant that could increase the efficacy of a CEA-specific cancer vaccine, which could provide an efficacious new strategy for cancer therapy.


Assuntos
Adjuvantes Imunológicos/genética , Ligante de CD40/genética , Ligante de CD40/imunologia , Vacinas Anticâncer/genética , Vacinas Anticâncer/imunologia , Antígeno Carcinoembrionário/imunologia , Vacinas contra Influenza/genética , Vacinas contra Influenza/imunologia , Adjuvantes Imunológicos/síntese química , Adjuvantes Imunológicos/uso terapêutico , Animais , Antígenos CD/biossíntese , Antígenos CD/fisiologia , Antígeno B7-1/biossíntese , Antígeno B7-1/fisiologia , Antígeno B7-2 , Ligante de CD40/uso terapêutico , Vacinas Anticâncer/síntese química , Vacinas Anticâncer/uso terapêutico , Antígeno Carcinoembrionário/uso terapêutico , Linhagem Celular Tumoral , Células Cultivadas , Citotoxicidade Imunológica/genética , Epitopos de Linfócito T/imunologia , Epitopos de Linfócito T/uso terapêutico , Feminino , Vacinas contra Influenza/síntese química , Vacinas contra Influenza/uso terapêutico , Glicoproteínas de Membrana/biossíntese , Glicoproteínas de Membrana/fisiologia , Camundongos , Camundongos Endogâmicos BALB C , Linfócitos T Citotóxicos/imunologia , Células Th1/imunologia , Células Th1/metabolismo , Transfecção , Vacinas Combinadas/síntese química , Vacinas Combinadas/genética , Vacinas Combinadas/imunologia , Vacinas Combinadas/uso terapêutico , Vacinas Virossomais/síntese química , Vacinas Virossomais/genética , Vacinas Virossomais/imunologia , Vacinas Virossomais/uso terapêutico
4.
Ophthalmology ; 109(6): 1167-71, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12045061

RESUMO

OBJECTIVE: To test CD-34 immunoreactivity in stromal cornea cells in normal and pathologic samples obtained from penetrating keratoplasty. DESIGN: Prospective, consecutive histopathologic human tissue study. PARTICIPANTS AND CONTROLS: One hundred two cornea buttons from patients with different diseases, submitted for cornea transplant, were examined. Controls were expired corneas from healthy donor patients who died (n = 4), and globes enucleated for primitive intraocular neoplasias, that is, retinoblastomas (n = 8), and malignant choroidal melanomas (n = 2). METHODS: The expression of CD-34 in stromal cornea cells was examined by immunohistochemistry analysis. Other immunohistochemical stains included an endothelial cell marker (CD-31), common leukocyte antigen, and alpha-smooth muscle actin. MAIN OUTCOME MEASURES: Different diseases that may cause blindness and require penetrating keratoplasty have been tested for CD-34 immunoreactivity. RESULTS: In control corneas, keratocytes present strong and consistent CD-34 immunoreactivity. Diseases leading to the loss of transparency and penetrating keratoplasty, such as keratoconus, herpes keratitis, trauma, and heredofamilial dystrophies, are associated with focal or diffuse loss of CD-34 expression, whereas pseudophakic bullous keratopathy and Fuchs' endothelial dystrophy show normal CD-34 immunoreactivity in most cases and patchy unstained stromal areas in a few cases. CONCLUSIONS: Scar tissue formation in the cornea, as in herpes keratitis and trauma, is always associated with loss of CD-34 immunoreactivity, which may otherwise be a primary event in keratoconus and heredofamilial dystrophies. Both in the pseudophakic bullous keratopathy and Fuchs' endothelial dystrophy, CD-34 immunoreactivity may be normal or lost, hence these two diseases may be considered as one and part of the same group with regard to CD-34 expression, as revealed by immunohistochemistry analysis.


Assuntos
Antígenos CD34/metabolismo , Doenças da Córnea/metabolismo , Substância Própria/metabolismo , Actinas/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças da Córnea/cirurgia , Feminino , Antígenos HLA/metabolismo , Humanos , Técnicas Imunoenzimáticas , Ceratoplastia Penetrante , Masculino , Pessoa de Meia-Idade , Molécula-1 de Adesão Celular Endotelial a Plaquetas/metabolismo
5.
J Cutan Pathol ; 29(1): 33-7, 2002 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11841515

RESUMO

BACKGROUND: Benign lymphoepithelial lesions (BLEL) are usually found in salivary glands in autoimmune disorders. Some LEL are recognized to already be, or may progress to become, lymphomas. Skin lesions similar to LEL have been described in lymphomas, and are caused by neoplastic lymphocytes which infiltrate adnexal structures. To date, BLEL have not widely been recognized in the skin. METHODS: We describe skin lesions similar to BLELs, at the periphery of squamous cell carcinomas (SCC) in 8 healthy patients, in one of whom the lesion recurred. Immunocharacterization of both epithelial and lymphocytic components and molecular genetic investigation was performed. Polymerase chain reaction (PCR) analysis was done to detect IgH chain gene, and T-cell receptor beta and gamma gene rearrangements. Association with Epstein-Barr virus (EBV) was also tested by in situ hybridization (ISH) for EBV-encoded RNAs (EBERs). RESULTS: Epithelial cells showed the immunophenotype of eccrine sweat gland ducts. Infiltrating lymphocytes expressed overwhelming B antigens and CD5. Neither clonal B and/or T proliferations nor EBERs signals were demonstrable. CONCLUSIONS: We observed skin lesions similar to BLELs, showing modifications of sweat gland duct and CD5+, B lymphocytic expansion. In our cases there were no associated autoimmune disorders; the local immunoresponse to SCC might have caused BLEL.


Assuntos
Carcinoma de Células Escamosas/patologia , Tecido Linfoide/patologia , Transtornos Linfoproliferativos/patologia , Neoplasias Cutâneas/patologia , Idoso , Idoso de 80 Anos ou mais , Antígenos CD/metabolismo , Biomarcadores Tumorais/metabolismo , Antígenos CD5/metabolismo , Antígenos CD79 , Carcinoma de Células Escamosas/complicações , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/metabolismo , DNA de Neoplasias/análise , Glândulas Écrinas/metabolismo , Glândulas Écrinas/patologia , Células Epiteliais/metabolismo , Células Epiteliais/patologia , Feminino , Humanos , Tecido Linfoide/metabolismo , Transtornos Linfoproliferativos/complicações , Transtornos Linfoproliferativos/genética , Transtornos Linfoproliferativos/metabolismo , Masculino , Pessoa de Meia-Idade , Receptores de Antígenos de Linfócitos B/metabolismo , Neoplasias Cutâneas/complicações , Neoplasias Cutâneas/genética , Neoplasias Cutâneas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA